Qnovia (Series B)

Funding Details
Awarder
Inbox
Date Award
May 30, 2025
Vertical
Pharmaceuticals
Funding URL
View Funding Page
Funding Amount:
$16,000,000

Company Info
Founding Year
2018
Founders
Mario Danek
Company Description
Qnovia is a pharmaceutical company focused on developing and commercializing proprietary inhalation device technologies to improve patient outcomes. The company's drug delivery platform, the RespiRx™, is the first orientation-agnostic, portable vibrating mesh nebulizer that effectively operates in any position held by the patient.
Market
Smoking cessation and respiratory health
Location
Richmond, Virginia, USA
Coinvestors
Blue Ledge Capital, Evolution VC Partners, Vice Ventures, Gaingels

Links